Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis)

Cancer Biology and Medicine

Volumn 10, Issue 3, 2013, Pages 148-157

  Bagaria, Bhawna ^a   Sood, Sadhna ^a   Sharma, Rameshwaram ^a   Lalwani, Soniya ^b  

^a SMS MEDICAL COLLEGE   (India)

^b Birla Institute of Scientific Research   (India)

Author keywords

Carbohydrate antigen 19 9, human; Carcinoembryonic antigen; Receiver operating characteristic curve; Sensitivity and specificity

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ESOPHAGUS CANCER; FEMALE; HUMAN; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; YOUNG ADULT;

EID: 84891342064     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2013.03.005     Document Type: Article

References (44)

1. Yeole B B. Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. Asian Pac J Cancer Prev 2008;9:97-100.
2. Lambert R, Saito H, Lucas E, Sankaranarayanan R. Survival from digestive cancer in emerging countries in Asia and Africa. Eur J Gastroenterol Hepatol 2012;24:605-612.
3. Pathy S, Lambert R, Sauvaget C, Sankaranarayanan R. The incidence and survival rates of colorectal cancer in India remain low compared with rising rates in East Asia. Dis Colon Rectum 2012;55:900-906.
4. The application and value of measuring serum CA72-4, CA19-9, CEA standard in cure of gastric carcinoma. Medical Research. Available online: http://mt.china-papers.com/2/?p=20219
5. Thomas S N, Zhu F, Schnaar R L, Alves C S, Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 2008;283:15647-15655.
6. Konstantopoulos K, Thomas S N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 2009;11:177-202.
7. Carcinoembryonic antigen-Wikipedia, the free encyclopedia. Cancer Diagnosis-Information about Cancer-Stanford Cancer Center. Retrieved 2008-10-15. Available online: http://en.wikipedia.org/wiki/Carcinoembryonic_antigen
8. Korkmaz M, Ünal H, Selçuk H, Yilmaz U. Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature. Turk J Gastroenterol 2010;21:461-463.
9. Carbohydrate antigen 19-9 (CA 19-9) (serum, plasma). The Association for Clinical Biochemistry 2012. Available online: http://www.acb.org.uk/docs/NHLM/CA19-9.pdf
10. Zweig M H, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin chem 1993;39:561-577.
11. Mao Y S, Zhang D C, Zhao X H, Wang L J, Qi J, Li X X. Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer. Zhonghua Zhong Liu Za Zhi 2003;25:457-460.
12. Schneider J, Bitterlich N, Schulze G. Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK. Anticancer Res 2005;25:1507-1515.
13. Choudhary A M, Ahmed M Z, Choudhary M S. Comparison of CEA and CA 19-9 with CA 72-4 in patients with upper gastrointestinal carcinomas in local population. Biomedica 2010;26:16-19.
14. Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg. 2004;28:680-685.
15. Hwang G I, Yoo C H, Sohn B H, Shin J H, Park Y L, Kim H D, et al. Predictive value of preoperative serum CEA, CA199 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma. Cancer Res Treat 2004;36:178-181.
16. Park S H, Ku K B, Chung H Y, Yu W. Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas. Cancer Res Treat 2008;40:16-21.
17. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003;6:142-145.
18. Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol M D. The use of tumor markers as predictors of prognosis in gastric cancer. Hepato Gastroenterology 2004;51:1544-1547.
19. Carpelan-Holmström M, Louhimo J, Stenman U H, Alfthan H, Järvinen H, Haglund C. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol 2004;25:228-234.
20. Palmqvist R, Engarås B, Lindmark G, Hallmans G, Tavelin B, Nilsson O, et al. Prediagnostic levels of Carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study. Dis Colon Rectum 2003;46:1538-1544.
21. Bayatti A A, Rawak K, Masraf R I. CEA, CA19-9, & AFP as tumor markers for colorectal carcinoma. J Fac Med Baghdad 2006;48:36-47.
22. Goldstein M J, Mitchell E P. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005;23:338-351.
23. Duffy M J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624-630.
24. Mealy K, Feely J, Reid I, McSweeney J, Walsh T, Hennessy T P. Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 1996;22:505-507.
25. Clinical significance of monitoring pre-operative CEA, CA 125, CA 19-9 and β-HCG serum level in esophageal cancer. Cancer Research>Esophagus Cancer>2011.08.25. Available online: http://www.cancer-res.com/esophagus-cancer/
26. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrateantigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001;32:41-44.
27. Patai A, Héber S, Döbrönte Z, Kovács L G. Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology. Orv Hetil 1992;133: 1301-4, 1307.
28. Yamao T, Kai S, Kazami A, Koizumi K, Handa T, Takemoto N, et al. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. Jpn J Clin Oncol 1999;29:550-555.
29. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008;25:1075-1084.
30. Tohru N, Terumitsu S, Takashi T, Masaaki J, Masayuki O, Atsushi N, et al. Prognostic value of circulating CA19-9 in colorectal cancer patients. Acta Med Nagasaki Ensia 2000;45:47-50.
31. Ahbeddou N, Bensouda Y, Fetohi M, Ahid S, Gutierrez M, Brain E, et al. Preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 serum levels: which usefulness in localised colorectal cancer? Eur J Oncol Med 2010;2:7-11.
32. Munck-Wikland E, Kuylenstierna R, Lindholm J, Wahren B. Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus. Anticancer Res 1990;10:703-708.
33. Zheng C X, Zhan W H, Zhao J Z, Zheng D, Wang D P, He Y L, et al. The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol 2001;7:431-434.
34. Louhimo J, Carpelan-Holmström M, Alfthan H, Stenman UH, Järvinen H J, Haglund C. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 2002;101:545-548.
35. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-369.
36. CA19-9 Immunoassays-MonobindInc 2013. Available online: http://www.monobind.com/immunoassays-cancer-markersca-19-9
37. Turkyilmaz A, Eroglu A, Aydin Y, Karaoglanoglu N. The relationship of serum CEA and CA 19-9 levels to liver metastasis and pancreatic invasion in esophageal cancer. Turk J Med Sci 2009;39:895-899.
38. Mattar R, Alves de Andrade C R, DiFavero G M, Gama-Rodrigues J J, Laudanna A A. Preoperative serum levels of CA72-4, CEA, CA 19-9, and Alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med S Paulo 2002;57:89-92.
39. Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000;3:177-186.
40. Tuncer I, Dülger H, Uygan I, Öztürk M, Kotan Ç, Şekeroǧlu R. Comparison of serum Cytokeratin- 18, CEA and CA19-9 levels in esophageal and gastric cancers. East J Med 2004;9:72-78.
41. Tsavaris N, Vonorta K, Tsoutsos H, Kozatsani-Halividi D, Mylonakis N, Papagrigoriou D, et al. Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC). Int J Biol Markers 1993;8:88-93.
42. El-Awady S, Lithy R, Morshed M, Khafagy W, Abd Monem H, Waleed O, et al. Utility of serum preoperative Carcinoembryonic antigen in colorectal cancer patients. Hepatogastroenterology 2009;56:361-366.
43. Ogata Y, Murakami H, Sasatomi T, Ishibashi N, Mori S, Ushijima M, et al. Elevated preoperative serum carcinoembryonic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. J Surg Oncol 2009;99:65-70.
44. Grotowski M. Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer. Pol Merkur Lekarski 2002;12:77-80.